|
|
|
Volumn 144, Issue 38, 2000, Pages 1844-1845
|
|
Consensus infliximab therapy in patients with Crohn's disease;Consensus infliximabbehandeling bij patienten met de ziekte van Crohn
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
INFLIXIMAB;
METHOTREXATE;
GASTROINTESTINAL AGENT;
IMMUNOLOGICAL ADJUVANT;
MONOCLONAL ANTIBODY;
CROHN DISEASE;
DRUG COST;
DRUG EFFECT;
DRUG INDICATION;
HUMAN;
IMMUNOMODULATION;
NETHERLANDS;
SHORT SURVEY;
ARTICLE;
CONSENSUS DEVELOPMENT;
ECONOMICS;
EXPERT WITNESS;
HOSPITALIZATION;
PRACTICE GUIDELINE;
ADJUVANTS, IMMUNOLOGIC;
ANTIBODIES, MONOCLONAL;
CONSENSUS DEVELOPMENT CONFERENCES;
CROHN DISEASE;
DRUG COSTS;
EXPERT TESTIMONY;
GASTROINTESTINAL AGENTS;
HUMANS;
NETHERLANDS;
PRACTICE GUIDELINES;
SEVERITY OF ILLNESS INDEX;
|
|
EID: 0034675193
PISSN: 00282162
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|
